Literature DB >> 14726679

Coupling apoptosis resistance to the cellular stress response: the IAP-Hsp90 connection in cancer.

Dario C Altieri1.   

Abstract

Understanding how tumor cells manage to survive and proliferate in ever-changing and often harmful microenvironments is a daunting challenge in tumor biology, and a major cause of treatment failure in the oncology clinic. Recent data have now demonstrated a direct link between the molecular chaperone Hsp90 and survivin, a dual regulator of cell proliferation and cell death over-expressed in virtually every human tumor. While the survivin-Hsp90 association may help tumor cells elevate their anti-apoptotic threshold and promote their proliferation, it may also provide new opportunities for rational cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726679     DOI: 10.4161/cc.3.3.711

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  4 in total

1.  Increased levels of survivin, via association with heat shock protein 90, in mucosal T cells from patients with Crohn's disease.

Authors:  Heitor S P de Souza; Gail A West; Nancy Rebert; Carol de la Motte; Judy Drazba; Claudio Fiocchi
Journal:  Gastroenterology       Date:  2012-06-26       Impact factor: 22.682

2.  Antichemosensitizing effect of resveratrol in cotreatment with oxaliplatin in HCT116 colon cancer cell.

Authors:  Dong-Guk Park
Journal:  Ann Surg Treat Res       Date:  2014-01-22       Impact factor: 1.859

3.  A novel therapeutic strategy for the treatment of glioma, combining chemical and molecular targeting of hsp90a.

Authors:  Adi Mehta; Leroy Shervington; Chinmay Munje; Amal Shervington
Journal:  Cancers (Basel)       Date:  2011-12-08       Impact factor: 6.639

Review 4.  Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics.

Authors:  Neerada Meenakshi Warrier; Prasoon Agarwal; Praveen Kumar
Journal:  Stem Cell Rev Rep       Date:  2020-10       Impact factor: 5.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.